Drug intelligence / Profile preview

taurolidine

Development stage
Phase 4
Lead developer
CorMedix
Modality
Small Molecules
Administration
Intracatheter, Intraperitoneal, Intravenous
01

Overview

Taurolidine is a synthetic broad-spectrum antimicrobial and anti-endotoxin agent derived from the amino acid taurine. Its mechanism of action involves the slow release of active methylol derivatives that chemically react with bacterial cell wall components (peptidoglycans) and neutralize bacterial toxins (endotoxins and exotoxins) through cross-linking. Unlike traditional antibiotics, taurolidine acts via a chemical reaction rather than a specific metabolic pathway, which minimizes the risk of developing bacterial resistance. Beyond its antimicrobial properties, taurolidine has demonstrated anti-neoplastic activity, particularly in glioblastoma and other solid tumors, by inducing apoptosis and inhibiting angiogenesis. It is widely used as a catheter lock solution to prevent catheter-related bloodstream infections (CRBSI) and has been investigated for the treatment of peritonitis and various cancers.

Brand names
TaurolinTauroSeptTauroLock
Other names
Bis(1,1-dioxoperhydro-1,2,4-thiadiazin-4-yl)methaneTaurolidinum
02

Targets

FimH (Type 1 fimbrial adhesin)

Beyond the preview

Go deeper on taurolidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on taurolidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call